tirzepatide surpass Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the Clinical Trial Program | Cardiovascular Diabetology SURPASS-2: Tirzepatide bests semaglutide in

GLP-1 medications reduce appetite, which may inadvertently decrease fluid intake

Heart & Cardiovascular Health Reducing cardiometabolic risk factors and supporting long-term cardiovascular resilience

Both drugs can help promote weight loss by mimicking hormones that help to reduce hunger and increase feelings of fullness after eating

Ask for Certificates of Analysis: A reputable peptide pharmacy should provide batch-specific COAs showing HPLC purity of 97% or higher, endotoxin levels, and sterility test results

Tirzepatide shows similar economics: Mounjaro's typical annual cost reaches $12,000-$15,600, while PlexusDx's compounded tirzepatide injection is $289/mo month-to-month, or from $249/mo on the 6-month plan or $3,468/year ($289/mo)ly